Mountain Valley MD plans private placement and debt settlement

Mountain Valley MD Holdings Inc. (CSE: MVMD) (OTC: MVMDF) announced plans for a non-brokered private placement offering to raise up to CAD $2 million and concurrent debt settlement transactions totaling CAD $485,000.

The company intends to issue up to 80 million units at CAD $0.025 per unit. Each unit consists of one common share and one warrant exercisable at CAD $0.08 per share for 12 months. The warrants may be accelerated if the volume-weighted average share price reaches CAD $0.12 for ten consecutive trading days on the Canadian Securities Exchange.

Mountain Valley MD expects to use net proceeds for general working capital purposes. The offering is scheduled to close in April 2026, subject to regulatory approvals including CSE acceptance. Securities will be subject to a four-month and one-day hold period under Canadian securities laws.

Simultaneously, the company plans two shares-for-debt transactions. The first transaction will settle CAD $385,000 of debt through common shares issued at CAD $0.017 per share. The second transaction will settle CAD $100,000 of debt with shares priced at CAD $0.06 each. Both transactions involve common shares only, without warrants.

The company stated the debt settlements are intended to substantially eliminate outstanding indebtedness and strengthen its balance sheet. The CSE previously approved the pricing for both the unit offering and the first debt settlement transaction under CSE Policy 6.

Mountain Valley MD develops delivery technologies including patented Quicksome oral formulation technology, Quicksol solubility technology, and licensed Agrarius agricultural plant signaling technology for applications in human health, animal health, and agriculture.

You May Also Be Interested In

• Osprey Acquisition Corp. III raises $300M in Nasdaq IPO
• ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise
• Nuvve unit agrees to acquire Romanian battery storage developer